These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 627795)

  • 1. Chlorthalidone in prevention of urinary calcium stone.
    Sidabutar RP; Lumenta NA; Suling RC
    J Med Assoc Thai; 1978 Jan; 61 Suppl 1():195-204. PubMed ID: 627795
    [No Abstract]   [Full Text] [Related]  

  • 2. The proper choice of agents to diminish hypercalciuria in urolithiasis.
    Gursel E; Zinsser HH
    Med Times; 1968 Nov; 96(11):1133-48. PubMed ID: 5704909
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recurrent oxalocalcium lithiasis. 2: Risk factors and prevention of recurrence of calcium urinary lithiasis].
    Réveillaud RJ; Daudon M
    Rev Prat; 1989 Feb; 39(4):317-23. PubMed ID: 2649970
    [No Abstract]   [Full Text] [Related]  

  • 4. [A study of allopurinol in the prevention of recurrent calcium oxalate stones].
    Sonoda T; Koide T; Oka T; Sakaguchi H; Itatani H; Ohkawa T; Ebisuno S; Morimoto S; Yoshida O; Okada Y
    Hinyokika Kiyo; 1985 Nov; 31(11):2071-9. PubMed ID: 4091144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
    Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
    J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Optimal dosage of chlorthalidone in the prevention of the recurrence of nephrolithiasis is 25 mg per day].
    Jaeger P; Portmann L; Jacquet AF; Bugnon JM; Burckhardt P
    Schweiz Med Wochenschr; 1986 Mar; 116(10):305-8. PubMed ID: 3961448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful sodium thiosulphate treatment for recurrent calcium urolithiasis.
    Yatzidis H
    Clin Nephrol; 1985 Feb; 23(2):63-7. PubMed ID: 3886226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary hyperparathyroidism in cases of urinary stone].
    Tajima A; Fujii K; Ohta N; Ohmi Y; Suzuki K; Aso Y
    Hinyokika Kiyo; 1984 Jul; 30(7):975-9. PubMed ID: 6507215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium oxalate calculus: therapy and prevention].
    Lutzeyer W
    Dtsch Med Wochenschr; 1969 Jan; 94(3):141. PubMed ID: 5782577
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria].
    Kurita Y; Kageyama S; Ishikawa A; Ushiyama T; Ohta N; Suzuki K; Kawabe K
    Hinyokika Kiyo; 1994 Jun; 40(6):479-83. PubMed ID: 8073954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What foods should stone formers avoid?].
    Amasaki N; Kurita T
    Hinyokika Kiyo; 2004 Aug; 50(8):573-5. PubMed ID: 15471079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medical management for the prevention of the recurrence of urolithiasis--with special recurrence to the patients who underwent percutaneous nephrolithotripsy (PNL) or extracorporeal shock wave lithotripsy (ESWL)].
    Yasukawa S
    Hinyokika Kiyo; 1989 Dec; 35(12):2107-13. PubMed ID: 2618911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental and clinical studies on calcium lithiasis. II. Prevention of recurrent calcium stones with thiazides and allopurinol].
    Okada Y; Nonomura M; Takeuchi H; Kawamura J; Yoshida O
    Hinyokika Kiyo; 1986 Sep; 32(9):1247-57. PubMed ID: 3812144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Administration of a diphosphonate in urinary calculi prevention].
    Baumann JM; Ganz U; Bisaz S; Fleisch H; Rutishauser G
    Helv Chir Acta; 1974 Sep; 41(4):421-4. PubMed ID: 4369478
    [No Abstract]   [Full Text] [Related]  

  • 15. [Compliance and active cooperation of patients in preventing recurrence of urinary calculi].
    Hoffmann L; Becher R; Erdmann T
    Z Urol Nephrol; 1979 Apr; 72(4):269-75. PubMed ID: 463369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The medical treatment of calcium lithiasis (author's transl)].
    Ulmann A
    J Urol (Paris); 1981; 87(1):27-9. PubMed ID: 7217703
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of relapse in urolithiasis (author's transl)].
    Bastian HP; Brühl P
    Munch Med Wochenschr; 1973 Nov; 115(46):2079-83. PubMed ID: 4591379
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemolysis of calcium containing urinary calculi. A review.
    Oosterlinck W; Verbeeck R
    Acta Urol Belg; 1994 Jun; 62(2):31-7. PubMed ID: 8037001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of Wofatit-KPS on persistent urolithiasis and suggestions for possible prevention].
    Ecke M
    Z Urol Nephrol; 1970 Oct; 63(10):741-6. PubMed ID: 5509083
    [No Abstract]   [Full Text] [Related]  

  • 20. [Guidelines for prevention of recurrent urolithiasis (author's transl)].
    Zechner O
    Wien Klin Wochenschr; 1981 Oct; 93(20):619-24. PubMed ID: 7324473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.